GENERAL KIDNEY STO
Total Payments
$132,665
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $132,665 | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $132,665 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The ShockPulse SE vs Trology Trial | Boston Scientific Corporation | $103,874 | 0 |
| Assessing Effects of Intrarenal Pressure using a Porcine Model | Boston Scientific Corporation | $27,000 | 0 |
| Stone clearance effectiveness of miniperc probes | Boston Scientific Corporation | $1,791 | 0 |
Top Doctors Receiving Payments for GENERAL KIDNEY STO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Bloomington, IN | $132,665 | 4 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $132,665
Product Information
- Type Device
- Total Payments $132,665
- Total Doctors 0
- Transactions 4
About GENERAL KIDNEY STO
GENERAL KIDNEY STO is a device associated with $132,665 in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2021 to 2021. In 2021, $132,665 was paid across 4 transactions to 0 doctors.
The most common payment nature for GENERAL KIDNEY STO is "Unspecified" ($132,665, 100.0% of total).
GENERAL KIDNEY STO is associated with 3 research studies, including "The ShockPulse SE vs Trology Trial" ($103,874).